Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review
- PMID: 24402174
- PMCID: PMC3917265
- DOI: 10.3390/md12010128
Astaxanthin: sources, extraction, stability, biological activities and its commercial applications--a review
Abstract
There is currently much interest in biological active compounds derived from natural resources, especially compounds that can efficiently act on molecular targets, which are involved in various diseases. Astaxanthin (3,3'-dihydroxy-β, β'-carotene-4,4'-dione) is a xanthophyll carotenoid, contained in Haematococcus pluvialis, Chlorella zofingiensis, Chlorococcum, and Phaffia rhodozyma. It accumulates up to 3.8% on the dry weight basis in H. pluvialis. Our recent published data on astaxanthin extraction, analysis, stability studies, and its biological activities results were added to this review paper. Based on our results and current literature, astaxanthin showed potential biological activity in in vitro and in vivo models. These studies emphasize the influence of astaxanthin and its beneficial effects on the metabolism in animals and humans. Bioavailability of astaxanthin in animals was enhanced after feeding Haematococcus biomass as a source of astaxanthin. Astaxanthin, used as a nutritional supplement, antioxidant and anticancer agent, prevents diabetes, cardiovascular diseases, and neurodegenerative disorders, and also stimulates immunization. Astaxanthin products are used for commercial applications in the dosage forms as tablets, capsules, syrups, oils, soft gels, creams, biomass and granulated powders. Astaxanthin patent applications are available in food, feed and nutraceutical applications. The current review provides up-to-date information on astaxanthin sources, extraction, analysis, stability, biological activities, health benefits and special attention paid to its commercial applications.
Figures
References
-
- Pashkow F.J., Watumull D.G., Campbell C.L. Astaxanthin: A novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol. 2008;101:58D–68D. - PubMed
-
- Roche F. Astaxanthin As a Pigmenter in Salmon Feed, Color Additive Petition 7C02 1 1, United States Food and Drug Administration. Hoffman-La Roche Ltd.; Basel, Switzerland: 1987. Astaxanthin: Human food safety summary; p. 43.
-
- Sarada R., Tripathi U., Ravishankar G.A. Influence of stress on astaxanthin production in Haematococcus pluvialis grown under different culture conditions. Process Biochem. 2002;37:623–627. doi: 10.1016/S0032-9592(01)00246-1. - DOI
-
- Ranga Rao A. Ph.D. Thesis. University of Mysore; Mysore, India: May 15 , 2011. Production of astaxanthin from cultured green alga Haematococcus pluvialis and its biological activities.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
